Anamed gets European nod for intracorneal lens
This article was originally published in Clinica
US firm Anamed has gained European go-ahead to sell its PermaVision intracorneal lens for correcting refractive errors of the eye. The company, which claims to be the first with marketing approval for intracorneal lenses, plans to launch the product for correcting hyperopia in the middle of next year.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.